| |
NEWLY AVAILABLE, NEWLY APPROVED
Lumbar Retraction System
|
Integra LifeSciences Holdings Corporation
has announced the launch of the LumbarTrak™ Lumbar
Retraction System, the latest addition
to the R&B Redmond™ line.
The LumbarTrak system is designed to be flexible enough to be used for many
lumbar and thoracic spinal procedures, from microdiscectomies to multilevel
fusions. The entire system is made of titanium, which is lighter and more
radiolucent than stainless steel. Integra LifeSciences points out that the
titanium blades provide enhanced visualization while still maintaining maximum
exposure to the surgical site. The blades are color-coded by length for easy
identification by the surgical staff, and are available in lengths up to
130 mm for larger patients and three widths for multiple procedure options.
Quick and long connectors are available to attach multiple blades to the
retractor system.
It is estimated that more than 250,000 lumbar fusion procedures will be performed in United States in 2006.
Integra sells the LumbarTrak system and the complete line of R&B Redmond instruments directly through its JARIT sales organization and through its Integra NeuroSciences® sales organization.
For more information, contact
Integra LifeSciences
311 Enterprise Drive
Plainsboro, NJ 08536
Phone 609-275-0500
Fax 609-275-3684
www.Integra-LS.com
|
Self-Locking Anchor
|
Smith & Nephew's Endoscopy division announced the release of the KINSA™ Suture
Anchor, which is designed to provide a fast, secure and consistent method of
repairing instability of the shoulder.
Smith & Nephew Endoscopy's KINSA Suture Anchor is designed with a self-locking,
sliding knot encased inside the anchor. This is intended to enable the surgeon
to position the anchor in the best possible position without having to worry
about where the knots will lie and avoid situations in which stacks of knots
that secure the repair can create irritation within the joint after surgery,
or can loosen, resulting in a release of the tension required for the best possible
repair.
Smith & Nephew notes that the KINSA Suture Anchor allows the surgeon to create a more consistent tissue attachment: the fixation can be adjusted simply by pulling the suture, not by sinking the anchor deeper into the bone, as required with competing devices for treating instability.
According to industry statistics, by 2010 the number of arthroscopic shoulder procedures in the United States is expected to increase 20% from the nearly 880,000 performed in 2004.
For more information, contact
Smith & Nephew Endoscopy
150 Minuteman Road
Andover MA 01810
Phone 978-749-1000
fax 978-749-1599
www.smith-nephew.com |
Cannulated Screw Delivery System
Endius Incorporated has announced addition of its
NorthStar™ Cannulated Screw Delivery System for use with
the company's Atavi product line.
The Endius Atavi System is designed
to assist surgeons in performing microdiscectomies, decompressions,
interbody fusions, and multilevel pedicular fixation and delivering
motion preservation technologies through a posterior, posterolateral
or straight lateral approach using the Atavi FlexPosure Retractor.
Endius comments that the simplified access should allow surgeons
to adapt their current surgical techniques to an MIS platform.
The new NorthStar system enables surgeons
to target pedicles via a percutaneous method and place pedicle
markers. Those markers create the target docking position for the
FlexPosure which simplifies the access and fixation portions of
the procedure, minimally invasively. The NorthStar system can also
be used to deliver the company’s TiTLE 2 cannulated screws
through a percutaneous approach.
NorthStar comes equipped with cannulated
screws (in sizes 5.5 mm x 40 mm up
to 7.5 mm x 50 mm), pedicle markers,
depth sleeves, dilator, marker inserter/extractor, cannulated
taps, cannulated locking screw drivers,
and guidewires.
To learn more, contact
Endius
23 West Bacon Street
Plainville, MA 02762
Phone 800-955-6358
Fax 508-695-2501
www.endius.com
|
New Allograft Formulation
Exactech, Inc. has announced that the Food and
Drug Administration has issued 510(k)
clearance for a new formulation of
the company's Optecure™ allograft, which includes
cortical cancellous bone chips.
Optecure+CCC is the latest addition to Exactech's platform of demineralized
bone matrix products. The Optecure+CCC
formulation contains osteoconductive
bone chips, providing surgeons
with a wider range of products for application-specific solutions.
Optecure+CCC is indicated for
use as a bone graft extender in
the extremities, spine and pelvis
and as a bone void filler in the
extremities and pelvis. Initial
surgeries are expected to take
place by the end of 2006, and a
national market launch is scheduled
for the first quarter of 2007.
For more information, contact
Exactech Inc.
2320 North West 66th Court
Gainesville, Florida 32653
Phone 800-392-2832
Fax 352-378-2617
www.exac.com
|
Pre-Filled Flowable Hemostat
Johnson & Johnson Wound Management, a division
of ETHICON, INC., announced the launch of SURGIFLO™ Hemostatic
Matrix with FlexTip, a pre-filled, flowable hemostat that offers
surgeons the option to customize the consistency of the product
and has a flexible tip for precise placement.
The new bendable applicator tip has
"memory" designed
to ensure it stays at the optimum angle
for easier access and exact product
placement. ETHICON notes that the product flows easily into
rough or uneven surfaces for complete
coverage and rapid hemostasis. When
mixed with thrombin, it has been shown to achieve hemostasis
in less than 2 minutes in an in vivo
animal spleen model.
SURGIFLO Hemostatic Matrix is indicated
for surgical procedures (except urologic and ophthalmic) for hemostasis,
when control of capillary, venous, and arteriolar bleeding by pressure,
ligature, and other conventional procedures is ineffective or impractical.
SURGIFLO Hemostatic Matrix can be used with or without thrombin to achieve hemostasis.
SURGIFLO Hemostatic Matrix cannot be used in the closure of skin incisions because it may interfere with the healing of skin edges. It is not indicated for use in intravascular compartments because of the risk of embolization and is not for use in patients with known allergies to porcine gelatin.
For more information, contact
ETHICON
Route 22 West
Somerville, NJ 08876
Phone 877-384-4266
www.ethicon.com
|
|
